PMID- 22258630 OWN - NLM STAT- MEDLINE DCOM- 20120716 LR - 20190412 IS - 1755-3245 (Electronic) IS - 0008-6363 (Linking) VI - 94 IP - 1 DP - 2012 Apr 1 TI - Unfavourable consequences of chronic cardiac HIF-1alpha stabilization. PG - 77-86 LID - 10.1093/cvr/cvs014 [doi] AB - AIMS: The hypoxia-inducible factor-1 (HIF-1) is the master modulator of hypoxic gene expression. The effects of chronically stabilized cardiac HIF-1alpha and its role in the diseased heart are not precisely known. The aims of this study were as follows: (i) to elucidate consequences of HIF-1alpha stabilization in the heart; (ii) to analyse long-term effects of HIF-1alpha stabilization with ageing and the ability of the HIF-1alpha overexpressing hearts to respond to increased mechanical load; and (iii) to analyse HIF-1alpha protein levels in failing heart samples. METHODS AND RESULTS: In a cardiac-specific HIF-1alpha transgenic mouse model, constitutive expression of HIF-1alpha leads to changes in capillary area and shifts the cardiac metabolism towards glycolysis with a net increase in glucose uptake. Furthermore, Ca(2+) handling is altered, with increased Ca(2)(+) transients and faster intracellular [Ca(2+)] decline. These changes are associated with decreased expression of sarcoplasmic/endoplasmic reticulum calcium ATPase 2a but elevated phosphorylation of phospholamban. HIF-1alpha transgenic mice subjected to transverse aortic constriction exhibited profound cardiac decompensation. Moreover, cardiomyopathy was also seen in ageing transgenic mice. In parallel, we found an increased stabilization of HIF-1alpha in heart samples of patients with end-stage heart failure. CONCLUSION: Changes induced with transgenic cardiac HIF-1alpha possibly mediate beneficial effects in the short term; however, with increased mechanical load and ageing they become detrimental for cardiac function. Together with the finding of increased HIF-1alpha protein levels in samples from human patients with cardiomyopathy, these data indicate that chronic HIF-1alpha stabilization drives autonomous pathways that add to disease progression. FAU - Holscher, Marion AU - Holscher M AD - Department of Cardiovascular Physiology, Universitatsmedizin, Georg-August-University Gottingen, Humboldtallee 23, 37073 Gottingen, Germany. FAU - Schafer, Katrin AU - Schafer K FAU - Krull, Sabine AU - Krull S FAU - Farhat, Katja AU - Farhat K FAU - Hesse, Amke AU - Hesse A FAU - Silter, Monique AU - Silter M FAU - Lin, Yun AU - Lin Y FAU - Pichler, Bernd J AU - Pichler BJ FAU - Thistlethwaite, Patricia AU - Thistlethwaite P FAU - El-Armouche, Ali AU - El-Armouche A FAU - Maier, Lars S AU - Maier LS FAU - Katschinski, Dorthe M AU - Katschinski DM FAU - Zieseniss, Anke AU - Zieseniss A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120118 PL - England TA - Cardiovasc Res JT - Cardiovascular research JID - 0077427 RN - 0 (Calcium-Binding Proteins) RN - 0 (HIF1A protein, human) RN - 0 (Hif1a protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (phospholamban) RN - EC 3.6.3.8 (Sarcoplasmic Reticulum Calcium-Transporting ATPases) RN - EC 7.2.2.10 (Atp2a2 protein, mouse) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Age Factors MH - Animals MH - Calcium Signaling/genetics MH - Calcium-Binding Proteins/metabolism MH - Capillaries/metabolism MH - Cardiomyopathies/genetics/*metabolism/physiopathology MH - Disease Models, Animal MH - Disease Progression MH - Gene Expression Regulation MH - Glucose/metabolism MH - Glycolysis/genetics MH - Heart Failure/genetics/*metabolism/physiopathology MH - Humans MH - Hypoxia-Inducible Factor 1, alpha Subunit/genetics/*metabolism MH - Mice MH - Mice, Transgenic MH - Myocytes, Cardiac/*metabolism MH - Phosphorylation MH - Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism MH - Time Factors MH - Up-Regulation MH - Ventricular Function, Left EDAT- 2012/01/20 06:00 MHDA- 2012/07/17 06:00 CRDT- 2012/01/20 06:00 PHST- 2012/01/20 06:00 [entrez] PHST- 2012/01/20 06:00 [pubmed] PHST- 2012/07/17 06:00 [medline] AID - cvs014 [pii] AID - 10.1093/cvr/cvs014 [doi] PST - ppublish SO - Cardiovasc Res. 2012 Apr 1;94(1):77-86. doi: 10.1093/cvr/cvs014. Epub 2012 Jan 18.